Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride and salt loading for vascular stiffness in adults with ADPKD
NL-OMON55149Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in autosomal dominant polycystic kidney disease (ADPKD) comparing Sodium chloride then sodium chloride + amiloride with Placebo then placebo + amiloride (2 arms). Primary endpoint: Central arterial stiffness. Started Mar 2022; status: recruiting.
02
Drugs
amiloridesodium chloride
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NL-OMON55149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55149.